Skip to main content

Recent News

  • Jun 02, 2020
    Military Air Force
    In the current issue of MMWR, the CDC reports that among military personnel starting basic training, the use of nonpharmaceutical interventions (NPI) may significantly reduce the risk of COVID-19 infection. NPIs advocated include screening measures, testing, administrative measures, quarantine, isolation, and source control, all as efforts to limit transmission COVID-19 in the community.
    Read Article
Dr. R Landewe highlights #EULAR2020 #COVID19 Guidelines: 1. RMD-patients do NOT have higher risk for complications 2. Rheumatologists SHOULD BE involved in management discussions 3. Potential shortages of sDMARDS and biologics @rheumnow https://t.co/sjQubD7mJL
k dao @KDAO2011 (  View Tweet)
Jun 03, 2020
Patients with RA-ILD vs RA only: More likely to be older, male, white and RF positive.
Mario Pompermayer, MD @pompermarioMD (  View Tweet)
Jun 03, 2020
SAPHO or PsA with CASPAR criteria? 1/3 of SAPHO pts meet PsA criteria (particularly active or hx of psoriasis). Interestingly, most with osteitis did not meet CASPAR criteria while those with synovitis did. #EULAR2020 @RheumNow #AB0738 https://t.co/G4p6OiocE3
Dr. Rachel Tate @uptoTate (  View Tweet)
Jun 03, 2020
Congratulations from all of us at the BRC to Professor Paul Emery OBE for being awarded a Meritorious Award at EULAR 2020 #EULAR2020goesvirtual #EULAR2020 #FightingRMDsTogether https://t.co/z9T4AZ5P0u
NIHR Leeds BRC @LeedsBRC (  View Tweet)
Jun 03, 2020
Guselkumab improved axial symptoms, over 24 weeks in active PsA patients with radiographic sacroiliitis. Post-hoc analysis from Discover1&2 studies (Prof P Helliwell). #OP0054. #EULAR2020, >GF

ARD & RMD Open @ARD_BMJ (  View Tweet)

Jun 03, 2020
Can fatigue in RA vary by bDMARD used?
David Liew @drdavidliew (  View Tweet)
Jun 03, 2020
17,500 people connected at moment at the largest e-Congress I could imagine #EULAR2020 #EULAR2020goesvirtual

Loreto Carmona 🖖 @carmona_loreto (  View Tweet)

Jun 03, 2020
You've got at least two good reasons not to forget about cardiovascular risk in ankylosing spondylitis. Traditional and inflammatory: it's the double whammy. Mike Nurmohamed from @Reade_020 #EULAR2020 @RheumNow https://t.co/GLH7wzvrLN
David Liew @drdavidliew (  View Tweet)
Jun 03, 2020
Use Of TNFi Before, During And The 1stY after Pregnancy Among Women With RA: Most of the women with RA were not treated with TNFi before or in pregnancy. Women w.
Dr Philip Robinson @philipcrobinson (  View Tweet)
Jun 03, 2020
Increased cardiovascular risk in: - AS patients (adj HR 4.6 vs non-rheum controls) - longer disease duration of inflammatory rheum disease (7% per year) in a Spanish national multicentre project (CARMA) w 5y follow-up Martin Martinez OP0002 #EULAR2020 @RheumNow htt
David Liew @drdavidliew (  View Tweet)
Jun 03, 2020
Consensus Statement: Use Of Jakinib Therapy In Immune Mediated Inflammatory Diseases: A consensus statement from @drpnash and others. Abstract AB0352. #EULAR2020 @RheumNow https://t.co/5uqwFoUglS https://t.co/fIZPWGHAPx
Dr Philip Robinson @philipcrobinson (  View Tweet)
Jun 03, 2020
Certolizumab Pegol: A Safe And Efficient Treatment In Patients With Uveitis During Pregnancy: Conclusion: CZP seems to be effective and safe in female patients with uveitis during pregnancy and neonates.
Dr Philip Robinson @philipcrobinson (  View Tweet)
Jun 03, 2020
Spinal Radiographic Progression in axSpA and the Impact Of Classification As non-radiographic Versus Radiographic Disease => Conclusion: Spinal structural damage is mainly restricted to patients with r-axSpA #OP0075 @XBaraliakos #EULAR2020 @RheumNow https://t.co/
Dr Philip Robinson @philipcrobinson (  View Tweet)
Jun 03, 2020
Population studies show #AS patients have a 36% increased risk of Cardiovascular mortality - most deaths being vascular disease relate #EULAR2020 https://t.co/H3CK81lEOb https://t.co/v6V5HlgRt1
Dr. John Cush @RheumNow (  View Tweet)
Jun 03, 2020
46,311 #RA patients from the Swedish Rheumatology Quality Register were assessed for venous thromboembolism (VTE) risk.
Dr. John Cush @RheumNow (  View Tweet)
Jun 03, 2020
Study of 21,525 RA patients in the Forward Databank finds 13.8% w/ lung disease (LD).RA-LD pts had more hospitalizations/deaths (HR 1.3) and 4 fold risk of resp-related events, not influenced by therapies.
Dr. John Cush @RheumNow (  View Tweet)
Jun 03, 2020
Case Controlled Study of 482 RA patients with ILD vs 741 RA w/o IL found an inverse relationship Between MTX exposure and ILD #EULAR2020 #OP0036 @RheumNow https://t.co/tfkBr0vyRP
Dr. John Cush @RheumNow (  View Tweet)
Jun 03, 2020
Slightly crazy to be attending EULAR from my study. But crazy times #EULAR2020 @RheumNow https://t.co/X52Ep09GX4
Dr Philip Robinson @philipcrobinson (  View Tweet)
Jun 03, 2020
I may not be allowed to go to Frankfurt for EULAR this year - but #EULAR2020 can come to me! Once again delighted to be tweeting for @RheumNow this meeting, and settling in for a big night in Australia of day 1 #EULAR2020goesvirtual (thanks @eular_org!) https://t.c
David Liew @drdavidliew (  View Tweet)
Jun 03, 2020
Waiting for godot....I mean #EULAR2020 https://t.co/mFP4Lwld4U
Dr. John Cush @RheumNow (  View Tweet)
Jun 03, 2020
×